Dr. Anders Michael Messersmith, DO

Dr. Messersmith practices at North Memorial Health - Robbinsdale Hospital in Robbinsdale, Minnesota, part of Sanford Health.

Dr. Messersmith's NPI, 1801205323, was assigned on August 8, 2014. Dr. Messersmith holds Minnesota license 76704.

Dr. Messersmith's primary practice is North Memorial Health - Robbinsdale Hospital, at 3300 Oakdale North, Robbinsdale, MN 55422 in Hennepin County. The practice phone is (763) 520-5200.

Dr. Messersmith's primary practice is North Memorial Health - Robbinsdale Hospital in Robbinsdale, Minnesota, part of Sanford Health. Dr. Messersmith is also affiliated with Methodist Hospital. The medical group on file is Emergency Physicians Professional Association (EPPA). Dmand AI also links Dr. Messersmith to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Messersmith practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Messersmith's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Messersmith's licenses on file in 3 states: Minnesota, Georgia and Texas.

CMS data shows 572 Medicare services from Dr. Messersmith across 5 procedure codes in 2024, for 387 Medicare patients. Medicare paid $45,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 387 Medicare patients who saw Dr. Messersmith in 2024. The largest group is 75 to 84, with 124 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Messersmith's median patient age at 53, with 56% women.

In 2024, Dr. Messersmith wrote 382 Medicare Part D claims for 246 patients. 91% of them were for generic drugs. CMS names the drug for 167 of them, across 8 drugs with 11 or more claims each, at $1,289 in total drug cost. In 2023, CMS named 199 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Messersmith for performance year 2024, reported as part of a group. Dr. Messersmith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Messersmith from 2 drug and device companies from 2019 to 2021. Food and beverage make up the largest share, 100% of the total. BTG International, Inc. paid the most, $98.